Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cluster of COVID-19 in northern France: A retrospective closed cohort study

Arnaud Fontanet, Laura Tondeur, View ORCID ProfileYoann Madec, View ORCID ProfileRebecca Grant, Camille Besombes, Nathalie Jolly, Sandrine Fernandes Pellerin, Marie-Noëlle Ungeheuer, Isabelle Cailleau, Lucie Kuhmel, Sarah Temmam, Christèle Huon, Kuang-Yu Chen, Bernadette Crescenzo, Sandie Munier, Caroline Demeret, Ludivine Grzelak, Isabelle Staropoli, Timothée Bruel, Pierre Gallian, Simon Cauchemez, Sylvie van der Werf, Olivier Schwartz, Marc Eloit, Bruno Hoen
doi: https://doi.org/10.1101/2020.04.18.20071134
Arnaud Fontanet
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
2PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arnaud.fontanet@pasteur.fr
Laura Tondeur
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoann Madec
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yoann Madec
Rebecca Grant
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
3Sorbonne Université, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Grant
Camille Besombes
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Jolly
4Center for Translational Sciences, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandrine Fernandes Pellerin
4Center for Translational Sciences, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Noëlle Ungeheuer
5ICAReB Biobanking Platform, Center for Translational Science, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Cailleau
6Direction de la recherche médicale, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucie Kuhmel
7Medical Center of the Pasteur Institute, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Temmam
8Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christèle Huon
8Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuang-Yu Chen
9RNA Biology of Influenza Virus, Department of Virology, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Crescenzo
10Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandie Munier
10Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Demeret
10Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludivine Grzelak
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
13Virus and Immunity Unit, Vaccine Research Institute, Department of Virology, Institut Pasteur, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Staropoli
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
13Virus and Immunity Unit, Vaccine Research Institute, Department of Virology, Institut Pasteur, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothée Bruel
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
13Virus and Immunity Unit, Vaccine Research Institute, Department of Virology, Institut Pasteur, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Gallian
14Etablissement Français du Sang, 93210, La Plaine-Saint-Denis, France
15Unité des Virus Émergents (UVE): Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Cauchemez
16Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie van der Werf
10Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Schwartz
11UMR 3569, Centre National de la Recherche Scientifique (CNRS)
12Université de Paris, France
13Virus and Immunity Unit, Vaccine Research Institute, Department of Virology, Institut Pasteur, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Eloit
8Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France
17National Veterinary School of Alfort, Maisons-Alfort, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Hoen
1Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background The Oise department in France has been heavily affected by COVID-19 in early 2020.

Methods Between 30 March and 4 April 2020, we conducted a retrospective closed cohort study among pupils, their parents and siblings, as well as teachers and non-teaching staff of a high-school located in Oise. Participants completed a questionnaire that covered history of fever and/or respiratory symptoms since 13 January 2020 and had blood tested for the presence of anti-SARS-CoV-2 antibodies. The infection attack rate (IAR) was defined as the proportion of participants with confirmed SARS-CoV-2 infection based on antibody detection. Blood samples from two blood donor centres collected between 23 and 27 March 2020 in the Oise department were also tested for presence of anti-SARS-CoV-2 antibodies.

Findings Of the 661 participants (median age: 37 years), 171 participants had anti-SARS-CoV-2 antibodies. The overall IAR was 25.9% (95% confidence interval (CI) = 22.6-29.4), and the infection fatality rate was 0% (one-sided 97.5% CI = 0 - 2.1). Nine of the ten participants hospitalised since mid-January were in the infected group, giving a hospitalisation rate of 5.3% (95% CI = 2.4 –9.8). Anosmia and ageusia had high positive predictive values for SARS-CoV-2 infection (84.7% and 88.1%, respectively). Smokers had a lower IAR compared to non-smokers (7.2% versus 28.0%, P <0.001). The proportion of infected individuals who had no symptoms during the study period was 17.0% (95% CI = – 23.4). The proportion of donors with anti-SARS-CoV-2 antibodies in two nearby blood banks of the Oise department was 3.0% (95% CI = 1.1 - 6.4).

Interpretation The relatively low IAR observed in an area where SARS-CoV-2 actively circulated weeks before confinement measures indicates that establishing herd immunity will take time, and that lifting these measures in France will be long and complex.

Funding Institut Pasteur, CNRS, Université de Paris, Santé publique France, Labex IBEID (ANR-10-LABX-62-IBEID), REACTing, EU grant Recover, INCEPTION project (PIA/ANR-16-CONV-0005).

Evidence before the study The first COVID-19 cases in France were reported on 24 January 2020. Substantial transmission has occurred since then, with the Oise department, north of Paris, one of the heaviest affected areas in the early stages of the epidemic in France. As of 13 April 2020, 98,076 cases had been diagnosed in France, including 5,379 deaths.

Epidemiological and clinical characteristics of patients with COVID-19 have been widely reported, but this has largely been centred on cases requiring medical care. What remains unclear at this stage is the extent to which SARS-CoV-2 infections may be asymptomatic or present as subclinical, non-specific symptoms. While extensive contact tracing has identified asymptomatic infections using RT-PCR testing, serologic detection of anti-SARS-CoV-2 antibodies is needed to determine the real infection attack rate and the proportion of all infections that are asymptomatic or subclinical.

Added value of this study Using a combination of serologic assays with high sensitivity and specificity for anti-SARS-CoV-2 antibodies, we conducted a retrospective closed cohort study. In a high school linked to a cluster of COVID-19 in the Oise department, we showed an overall infection attack rate (IAR) of 40.9% in the high school group, and 10.9% in parents and siblings of the pupils. The proportion of infected individuals who had no symptoms during the study period was 17.0%.

Implications of all of the available evidence The relatively low IAR in this area where SARS-CoV-2 actively circulated before confinement measures were introduced indicates that establishing herd immunity will take time, and that the lifting of these measures in France will be long and complex.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04325646

Funding Statement

Institut Pasteur, CNRS, Université de Paris, Santé publique France, Labex IBEID (ANR-10-LABX-62-IBEID), REACTing, EU grant Recover, INCEPTION project (PIA/ANR-16-CONV-0005).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cluster of COVID-19 in northern France: A retrospective closed cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cluster of COVID-19 in northern France: A retrospective closed cohort study
Arnaud Fontanet, Laura Tondeur, Yoann Madec, Rebecca Grant, Camille Besombes, Nathalie Jolly, Sandrine Fernandes Pellerin, Marie-Noëlle Ungeheuer, Isabelle Cailleau, Lucie Kuhmel, Sarah Temmam, Christèle Huon, Kuang-Yu Chen, Bernadette Crescenzo, Sandie Munier, Caroline Demeret, Ludivine Grzelak, Isabelle Staropoli, Timothée Bruel, Pierre Gallian, Simon Cauchemez, Sylvie van der Werf, Olivier Schwartz, Marc Eloit, Bruno Hoen
medRxiv 2020.04.18.20071134; doi: https://doi.org/10.1101/2020.04.18.20071134
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cluster of COVID-19 in northern France: A retrospective closed cohort study
Arnaud Fontanet, Laura Tondeur, Yoann Madec, Rebecca Grant, Camille Besombes, Nathalie Jolly, Sandrine Fernandes Pellerin, Marie-Noëlle Ungeheuer, Isabelle Cailleau, Lucie Kuhmel, Sarah Temmam, Christèle Huon, Kuang-Yu Chen, Bernadette Crescenzo, Sandie Munier, Caroline Demeret, Ludivine Grzelak, Isabelle Staropoli, Timothée Bruel, Pierre Gallian, Simon Cauchemez, Sylvie van der Werf, Olivier Schwartz, Marc Eloit, Bruno Hoen
medRxiv 2020.04.18.20071134; doi: https://doi.org/10.1101/2020.04.18.20071134

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2467)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4844)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)